Theralase Technologies OTC Stock Top Insiders

TLTFF Stock  USD 0.19  0.01  5.00%   
Theralase Technologies employs about 12 people. The company is managed by 7 executives with a total tenure of roughly 20 years, averaging almost 2.0 years of service per executive, having 1.71 employees per reported executive. Examination of Theralase Technologies' management performance can provide insight into the company performance.
Roger DumoulinWhite  CEO
President CEO, Director
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Theralase Technologies. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in census.

Theralase Technologies Management Team Effectiveness

The company has return on total asset (ROA) of (0.5866) % which means that it has lost $0.5866 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.131) %, meaning that it generated substantial loss on money invested by shareholders. Theralase Technologies' management efficiency ratios could be used to measure how well Theralase Technologies manages its routine affairs as well as how well it operates its assets and liabilities.

Theralase Technologies Workforce Comparison

Theralase Technologies is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 243,647. Theralase Technologies adds roughly 12.0 in number of employees claiming only tiny portion of equities under Health Care industry.

Theralase Technologies Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Theralase Technologies Price Series Summation is a cross summation of Theralase Technologies price series and its benchmark/peer.

Theralase Technologies Notable Stakeholders

A Theralase Technologies stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Theralase Technologies often face trade-offs trying to please all of them. Theralase Technologies' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Theralase Technologies' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Roger DumoulinWhitePresident CEO, DirectorProfile
Lori LeachMarketing ConsultantProfile
Terry DVMEquine ConsultantProfile
David BAPres DivisionProfile
DSc MDChief CEOProfile
Vaughn WyantMarketing ConsultantProfile
Kristina CPACFO DirectorProfile

About Theralase Technologies Management Performance

The success or failure of an entity such as Theralase Technologies often depends on how effective the management is. Theralase Technologies management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Theralase management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Theralase management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research and development of photo dynamic compounds and their associated drug formulations to treat cancer, bacteria, and viruses in Canada, the United States, and internationally. Theralase Technologies Inc. was founded in 1994 and is based in Toronto, Canada. Theralase Technologi operates under Medical Devices classification in the United States and is traded on OTC Exchange.
The data published in Theralase Technologies' official financial statements typically reflect Theralase Technologies' business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Theralase Technologies' quantitative information. For example, before you start analyzing numbers published by Theralase accountants, it's essential to understand Theralase Technologies' liquidity, profitability, and earnings quality within the context of the Health Care Equipment & Supplies space in which it operates.

Theralase Technologies Workforce Analysis

Traditionally, organizations such as Theralase Technologies use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Theralase Technologies within its industry.

Theralase Technologies Manpower Efficiency

Return on Theralase Technologies Manpower

Revenue Per Employee65.1K
Revenue Per Executive111.5K
Net Loss Per Employee367.6K
Net Loss Per Executive630.2K

Complementary Tools for Theralase OTC Stock analysis

When running Theralase Technologies' price analysis, check to measure Theralase Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theralase Technologies is operating at the current time. Most of Theralase Technologies' value examination focuses on studying past and present price action to predict the probability of Theralase Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theralase Technologies' price. Additionally, you may evaluate how the addition of Theralase Technologies to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities